Medical Health & Life Science Research News

Report explores the Asia-Pacific's protein A resins market was worth $73.75 million in 2016

The Asia-Pacific Protein A Resins Market was worth $73.75 million in 2016 and estimated to be growing at a CAGR of 9.3%, to reach $115.04 million by 2021. The market is showcasing evident potential during the forecast period owing to increasing research on monoclonal antibodies which is anticipated to drive the sales of Protein A resins.

- Advertising -

Monoclonal antibodies can be defined as an antibody produced by a single clone of cells; these antibodies can be produced in large quantities in the laboratory. They can also be used to carry drugs, toxins, or radioactive substances straight to cancer cells.

Monoclonal antibodies have been showing promising results in the management of chronic diseases such as cancers and rheumatoid arthritis.

Browse market data tables and in-depth TOC of the Asia-Pacific Protein A Resins Market to 2021 @ www.marketdataforecast.com/market-…esins-market-382/

Asia-Pacific market for Protein A Resins is driven by factors such as high government support and increasing disposable income.

- Advertising -

Growing demand for biosimilars and increasing investments in the development of biosimilar products are also some of the key factors driving the market growth.

However increasing awareness about alternate methods to purify monoclonal antibodies is hampering the Protein A Resins market. High costs associated with the Protein A resins is also a major factor restraining the market growth.

Free sample of the report is available @ www.marketdataforecast.com/market-…82/request-sample

Asia-Pacific Protein A resin market is segmented on the basis of product type, application, matrix type and end user. By product the market is further segmented Natural Protein A Resin and Recombinant Protein A Resin.

Recombinant Protein A segment is estimated to be the fastest growing within this segment. On the basis of application protein A resin market is classified as Immuno precipitation and Antibody Purification.

Based on Matrix type Asia-Pacific Protein A Resin market is analyzed as Glass or Silica, Agarose and Organic Polymer. Within the matrix type agarose accounts for the largest share and is estimated to maintain its strong share during the forecast period.

By end user market is segmented into Biopharmaceutical Manufacturers, Clinical Research Laboratories and Academic Institutions

Inquire report @ www.marketdataforecast.com/market-…arket-382/inquire

Based on geography Asia-Pacific Protein A resin market is analysed under various regions namely China, Japan, India, South Korea and Australia. Asia Pacific region is estimated to be the fastest growing region with a CAGR of XX% owing to large number of untapped markets and growing awareness about the developments in the market.

Within Asia-Pacific Japan is the largest market for Protein A Resin accounting for a share of approximately XX% whereas India is estimated to be the fastest growing region due to lot of untapped markets.

Avail report @ www.marketdataforecast.com/market-…/request-discount

Some of the key companies covered in the report are GE Healthcare, Repligen Corporation, Novasep, Tosoh Bioscience, GenScript, Thermo Fisher Scientific, EMD Millipore and Expedeon Ltd.

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...